Interaction of major facilitator superfamily domain containing 2A with the blood-brain barrierYilun Ma，Taiwei Dong，Fei Luan，Juanjuan Yang，Feng Miao，Peifeng Wei2133-2152
Bidirectional regulation of the brain-gut-microbiota axis following traumatic brain injuryXinyu You，Lin Niu，Jiafeng Fu，Shining Ge，Jiangwei Shi，Yanjun Zhang，Pengwei Zhuang2153-2168
Interconnections between diabetic corneal neuropathy and diabetic retinopathy:diagnostic and therapeutic implicationsMingyi Yu，Faith Teo En Ning，Chang Liu，Yu-Chi Liu2169-2180
Utilizing engineered extracellular vesicles as delivery vectors in the management of ischemic stroke:a special outlook on mitochondrial deliveryJiali Chen，Yiyang Li，Xingping Quan，Jinfen Chen，Yan Han，Li Yang，Manfei Zhou，Greta Seng Peng Mok，Ruibing Wang，Yonghua Zhao2181-2198
Neuroprotective potential for mitigating ischemia-reperfusion-induced damageZi Ye，Runqing Liu，Hangxing Wang，Aizhen Zuo，Cen Jin，Nan Wang，Huiqi Sun，Luqian Feng，Hua Yang2199-2217
Diabetic peripheral neuropathy and neuromodulation techniques:a systematic review of progress and prospectsRahul Mittal，Keelin McKenna，Grant Keith，Evan McKenna，Joana R.N.Lemos，Jeenu Mittal，Khemraj Hirani2218-2230
C-C motif chemokine ligand 2/C-C motif chemokine receptor 2 pathway as a therapeutic target and regulatory mechanism for spinal cord injuryXiangzi Wang，Xiaofei Niu，Yingkai Wang，Yang Liu，Cheng Yang，Xuyi Chen，Zhongquan Qi2231-2244
Neuronal regulated cell death in aging-related neurodegenerative diseases:key pathways and therapeutic potentialsRun Song，Shiyi Yin，Jiannan Wu，Junqiang Yan2245-2263
Glycolytic dysregulation in Alzheimer's disease:unveiling new avenues for understanding pathogenesis and improving therapyYou Wu，Lijie Yang，Wanrong Jiang，Xinyuan Zhang，Zhaohui Yao2264-2278
Decoding molecular mechanisms:brain aging and Alzheimer's diseaseMahnoor Hayat，Rafay Ali Syed，Hammad Qaiser，Mohammad Uzair，Khalid Al-Regaiey，Roaa Khallaf，Lubna Abdullah Mohammed Albassam，Imdad Kaleem，Xueyi Wang，Ran Wang，Mehwish S.Bhatti，Shahid Bashir2279-2299
